ArticleFrontiers in nutrition2025
Global burden of lip and oral cavity cancer attributable to high alcohol consumption from 1990 to 2021.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Based on data from the Global Burden of Disease (GBD) 2021, this study analyzes the global disease burden of lip and oral cavity cancer attributable to high alcohol consumption (LOC-HAC). Methods: Disability-adjusted life years (DALYs) were used to assess health loss. The Das Gupta decomposition method was employed to analyze the effects of population growth, aging, and epidemiological changes on DALYs. The Nordpred model was applied to project the disease burden trends from 2022 to 2045. Results: In 2021, the global number of DALY cases for LOC-HAC was 1,191,084 (95% UI: 906,229.2-1,474,007), representing a 90% increase from 628,484.1 (95% UI: 493,522.1-754,895.3) in 1990. The fastest growth occurred in low-middle SDI regions, reaching 279%. A similar increasing trend was observed in deaths, with Southeast Asia showing the most significant rise, where DALYs and deaths increased by 326 and 357%, respectively. The global age-standardized DALY rate (ASDR) of LOC-HAC in 2021 was 13.66 (95% UI: 10.4-16.9) per 100,000 population, with Central Europe having the highest ASDR and Southeast Asia experiencing the fastest growth. DALYs and deaths were significantly higher in males than in females and increased with age, peaking at 55-59 years in males and 60-64 years in females. SDI levels were positively correlated with ASDR and age-standardized mortality rates (ASMR). However, when the SDI exceeded 0.75, ASDR and ASMR showed a declining trend. Over the past 32 years, the global increase in DALYs and deaths has been primarily driven by population aging and growth. Projections indicate that from 2022 to 2045, DALYs and deaths among males will rise significantly, whereas the increase among females will be more gradual. Conclusion: The global burden of LOC-HAC has risen significantly over the past decades, especially in low-middle SDI regions and Southeast Asia. In the future, efforts should focus on these regions by promoting healthier lifestyles, strengthening early screening, and optimizing healthcare resource allocation to reduce disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.